Transcriptome-based polygenic score links depression-related corticolimbic gene expression changes to sex-specific brain morphology and depression risk.

Saved in:
Bibliographic Details
Title: Transcriptome-based polygenic score links depression-related corticolimbic gene expression changes to sex-specific brain morphology and depression risk.
Authors: Miles AE; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada., Dos Santos FC; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada., Byrne EM; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia., Renteria ME; Department of Genetics & Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.; School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia., McIntosh AM; Division of Psychiatry, University of Edinburgh, Edinburgh, UK.; Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK., Adams MJ; Division of Psychiatry, University of Edinburgh, Edinburgh, UK., Pistis G; Department of Psychiatry, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Castelao E; Department of Psychiatry, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Preisig M; Department of Psychiatry, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Baune BT; Department of Psychiatry, University of Münster, Münster, Nordrhein-Westfalen, Germany.; Department of Psychiatry, Melbourne Medical School, University of Melbourne, Melbourne, Australia.; Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia., Schubert KO; Department of Psychiatry, University of Adelaide, Adelaide, Australia.; Northern Adelaide Mental Health Services, SA Health, Salisbury, Australia., Lewis CM; Social, Genetic and Developmental Psychiatry Centre, King's College London, London, UK.; Department of Medical & Molecular Genetics, King's College London, London, UK., Jones LA; Department of Psychological Medicine, University of Worcester, Worcester, UK., Jones I; MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK., Uher R; Department of Psychiatry, Dalhousie University, Halifax, NS, Canada., Smoller JW; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.; Psychiatric and Neurodevelopmental Genetics Unit (PNGU), Massachusetts General Hospital, Boston, MA, USA.; Stanley Center for Psychiatric Research, Broad Institute, Cambridge, MA, USA., Perlis RH; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.; Department of Psychiatry, Harvard Medical School, Boston, MA, USA., Levinson DF; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA., Potash JB; Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA., Weissman MM; Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY, USA.; Division of Translational Epidemiology, New York State Psychiatric Institute, New York, NY, USA., Shi J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Lewis G; Division of Psychiatry, University College London, Faculty of Brain Sciences, London, UK., Penninx BWJH; Department of Psychiatry, Vrije Universiteit Medical Center and GGZ inGeest, Amsterdam, Netherlands., Boomsma DI; Department of Biological Psychology & EMGO+ Institute for Health and Care Research, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Hamilton SP; Department of Psychiatry, Kaiser Permanente Northern California, San Francisco, CA, USA., Sibille E; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada., Hariri AR; Laboratory of NeuroGenetics, Department of Psychology and Neuroscience, Duke University, Durham, NC, USA., Nikolova YS; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada. yuliya.nikolova@camh.ca.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. yuliya.nikolova@camh.ca.
Corporate Authors: Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium
Source: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2021 Dec; Vol. 46 (13), pp. 2304-2311. Date of Electronic Publication: 2021 Sep 29.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8904907 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1740-634X (Electronic) Linking ISSN: 0893133X NLM ISO Abbreviation: Neuropsychopharmacology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1740-634X
DOI:10.1038/s41386-021-01189-x